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1122-170 Expression of Tob by Human Coronary Arteries and 
BMP-Mediated Stimulation of Coronary Artery 
Endothelial Cell Proliferation
Jun Xu, Terence M. Doherty, Di Chen, Shuang Chen, Pinky V. Tripathi, Suzhen Guo, Ejaz 
Ahmad, Lorraine A. Fitzpatrick, Tadashi Yamamoto, Prediman K. Shah, Tripathi B. 
Rajavashisth, Cedars-Sinai Medical Center, Los Angeles, CA, David Geffen School of 
Medicine at UCLA, Los Angeles, CA
Background: Little is known regarding the role of bone morphogenetic protein (BMP)
signaling that control vascular cell growth during normal homeostasis and in arterial
pathologies, notably atherosclerosis and arterial calcification. Here we tested the hypoth-
eses that Tob, an antiproliferative protein that negatively regulates BMP signaling, is
expressed in human coronary arteries and in cultured human coronary artery endothelial
cells (ECs) and that BMP2 stimulates proliferation in cultured ECs. Methods and
Results: Immunohistochemical localization showed abundant expression of Tob in ECs
of normal human arteries. We therefore determined expression of Tob and BMP receptor
(BMPR)-IA, -IB, and II in cultured ECs at baseline and stimulated with BMP2 (300 ng/mL
for 6 hr). Experiments were also performed in the presence of the proteasome inhibitor
epoxomicin that enhances BMP signaling by preventing degradation of BMP signaling
pathway components. ECs expressed Tob and BMPR-IA and -II, but did not express
BMPR-IB. Stimulation with either BMP2 or epoxomicin resulted in a significant increase
in expression of BMPR-IA and BMPR-II (p < 0.01 for both BMP2 and epoxomicin), but
there was no change in Tob mRNA. Stimulation of ECs with either BMP2 or epoxomicin
significantly increased proliferation measured by both a colorimetric proliferation assay (p
< 0.001 for both BMP2 and epoxomicin; n = 5) and by proliferating cell nuclear antigen
(PCNA) assay (p < 0.0.05 and 0.006; n = 3) after 48 hr in a dose-dependent manner. Tox-
icity was observed at high doses of epoxomicin. Conclusions: The antiproliferative BMP
pathway inhibitor Tob and BMPR-IA and II are abundantly expressed by human coronary
artery ECs both in vitro and in vivo. Expression of BMPR but not Tob transcripts are
affected by both BMP2 and epoxomicin. BMP2 may regulate EC proliferation, suggesting
a possible role in the growth of ECs during normal homeostasis and in arterial patholo-
gies involving EC denudation or proliferation. Since Tob has been implicated as an anti-
proliferative regulator in many other cell types, it may also regulates EC proliferation via a
mechanism that is not dependent on altered transcription of Tob in response to BMP
stimulation.
1122-171 Atherogenic Low-Density Lipoprotein Impairs Vascular 
Endothelial Cell Survival by Disrupting the FGF2-PI3K-
Akt Autoregulatory Loop
Wei Jiang, Jonathan Lu, Jun-Hai Yang, Po-Yuang Chang, Yuan-Teh Lee, Marco Marcelli, 
Philip D. Henry, Warren S. Liao, Chu-Huang Chen, Baylor College of Medicine, Houston, 
TX, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Background:
Atherogenic LDL, such as circulating electronegative LDL and oxidized LDL (oxLDL), can
inhibit proliferation and induce apoptosis in vascular endothelial cells (EC). Fibroblast
growth factor 2 (FGF2) stimulates phosphatidylinositol 3-kinase (PI3K), which in turn acti-
vates Akt, a protein kinase that regulates cell survival. This study was designed to inves-
tigate how oxLDL interferes with signal transduction along the FGF2-PI3K-Akt pathway.
Methods:
The interrelationship between FGF2 and Akt was examined in cultured bovine aortic EC
(BAEC). To investigate further the role of endogenous FGF2 in EC survival,
BAEC[FGF2(+)] and BAEC[FGF2(–)] cell lines were established by stable transfection of
BAEC with FGF2 sense and antisense cDNAs.
Results:
In cultured BAEC, oxLDL (50 µg/mL) inhibited FGF2 transcription and Akt phosphoryla-
tion, leading to marked apoptosis. Consistent with the cell-survival properties of Akt,
PI3K inhibitor wortmannin (25-200 nM) also inhibited FGF2 expression and induced apo-
ptosis in a concentration-dependent manner. Stable overexpression of FGF2 in
BAEC[FGF2(+)] greatly enhanced Akt phosphorylation, rendering the cells resistant to
oxLDL. In contrast, deprivation of endogenous FGF2 in BAEC[FGF2(–)] led to reduced
Akt phosphorylation and enhanced spontaneous apoptosis. Inhibition of FGF2 protein
synthesis by the antisense RNA also led to inhibition of FGF2 transcription in
BAEC[FGF2(–)], suggesting that endogenously produced FGF2 may be the most impor-
tant stimulator of its own induction in the low-serum, mitogen-free culture system. Fur-
thermore, G2/M transition in the cell cycle and DNA synthesis were severely inhibited in
BAEC[FGF2(–)], limiting proliferation. In contrast, unlike the parental BAEC,
BAEC[FGF2(+)] were resistant to the inhibitory effects of oxLDL on G2/M transition and
DNA synthesis.
Conclusion:
EC survival depends on continuous activation of the PI3K-Akt pathway by endogenous
FGF2, which is required for its own induction in the manner of an autocrine. Maintenance
of the integrity of the FGF2-PI3K-Akt autoregulatory loop is essential for EC survival in
the presence of atherogenic lipoproteins including oxLDL.
1122-172 Homocysteine Induced Endothelial Cell Damage 
Through NF-κB Activation and Monocyte 
Chemoattractant Protein-1 and Vascular Cell Adhesion 
Molecule-1 Expression
Hae-Young Lee, Dae-Gyun Park, Hyo-Soo Kim, Young-Bae Park, Seoul National 
University College of Medicine, Seoul, South Korea
Background & Aim: Homocysteine is known to damage endothelial cells by oxidative
stress, most studies were however performed with excessively high concentration. In
order to evaluate the action mechanism of homocysteine in clinically relevant concentra-
tion, S-adenosylhomocysteine (SAH) was induced intracellularly and NF-κB, the impor-
tant transcriptional regulator for oxidative stress, and its downstream mediators, MCP-1
and VCAM-1 expressions, were evaluated.
Methods: SAH was formed in human umbilical vein endothelial cells (HUVECs) by
administering homocystine, adenosine, and erythro-9-(2-hydroxy-3-nonyl) adenine to the
culture media and HUVECs were incubated for 72 hours. Intracellular reactive oxygen
species (ROS) formation was quantified by fluorescent intensity of dichlorofluorescin
(DCF) with confocal microscope. The proliferation and survival of HUVECs were evalu-
ated by [3H]-Thymidine uptake and MTT assay. NF-κB activity, MCP-1 secretion and
VCAM-1 expression were assayed by EMSA, ELISA and Western blot respectively.
Results: HUVECs showed atrophic change after intracellular SAH formation and the
deterioration was progressive according to time and concentration.
Intracellular ROS production evaluated by DCF fluorescence was increased. The cell
proliferation rates evaluated by [3H]-Thymidine uptake were decreased both in 40µM
SAH group (148 ± 47 CPM) and 200µM SAH group (139 ± 50 CPM) (control=207 ± 22
CPM) and the cell survival rates assayed by MTT uptake were also decreased both in
lower and higher SAH groups (156 ± 12 CPM and 106 ± 13 CPM) compared with control
(185 ± 10CPM).
NF-κB was activated by SAH induction, which was followed by increased MCP-1 secre-
tion and VCAM-1 expression.
Conclusion: We have shown that homocysteine damaged endothelial cells even in clini-
cally relevant concentrations through sustained exposure with intracellular SAH forma-
tion. And intracellular ROS production and NF-κB activation were observed and MCP-1
secretion and VCAM-1 expression might lead to inflammatory response in SAH-treated
endothelial cells. These data identified novel mechanism of homocysteine inducing
endothelial cell damage.
1122-173 Changes in Innate and Adaptive Humoral Immune 
Responses and Indices of Atherosclerosis in Aging
Kuang-Yuh Chyu, Paul C. Dimayuga, Stephanie M. Babbidge, Juliana Yano, Odette 
Reyes, Bojan Cercek, Prediman K. Shah, Cedars-Sinai Medical Center, Los Angeles, CA
Background: Immunization against atherosclerosis is a promising therapy but the natu-
ral course of immune responses against oxLDL during aging is not known. We hypothe-
sized that aging alters innate or adaptive immune responses to oxLDL modulating the
progression of atherosclerosis and plaque phenotype in apoE -/- mice. Method: Mice on
Western diet were sacrificed at 15-17, 36 or >50 weeks of age. Descending aorta was
stained en-face for lipids. Plaque lipid, macrophage and collagen content were evaluated
in the aortic sinus. Innate immune response was assessed using anti Cu-oxLDL and anti
phosphorylcholine (PC) IgM and adaptive immune response to oxLDL was assessed
using anti MDA-LDL and Cu-oxLDL IgG titers. Splenic cytokines were evaluated using
RT-PCR. Result: (Table) Aging was associated with increased atherosclerotic burden
and collagen content with decreased macrophage and plaque lipid. MDA-LDL IgG
increased in the 36 weeks group but reduced in mice >52 weeks. Cu-oxLDL and PC-IgM
increased significantly with age with cross-reactivity to each other. Cu-oxLDL IgG
increased with age with no isotype specificity. Splenic T-helper cytokine mRNA expres-
sion also increased with age. Conclusion: Innate immune response as indicated by anti-
body titers to CuoxLDL and PC is associated with increased plaque sizes and a more
stable phenotype. 
†Densitometric units relative to β-actin; ¶p<0.05 vs. 36 wk; ‡p<0.05 vs. 17 wk; IgG and
IgM ELISAs n=5 for 15-17 and 36 weeks and n=6 for >52 weeks; expressed as OD 405
1122-174 Thrombin and Histamine Stimulate Phosphorylation of 
Endothelial Nitric Oxide-Synthase via an Akt-
Independent, AMP-Activated Kinase-Dependent 
Pathway
Brynhildur Thors, Haraldur Halldórsson, Gudmundur Thorgeirsson, Institute of 
Pharmacy, Pharmacology and Toxicology, University of Iceland, Reykjavik, Iceland, 
Landspitali-University Hospital, Reykjavik, Iceland
Background: The protein kinase Akt is involved in vascular development and several
endothelial functions, including activation of endothelial NO-synthase (eNOS) and pro-
motion of endothelial cell survival. Recently we have found that although Akt-phosphory-
lation is inhibited by the G-protein activators thrombin and histamine these agonists
stimulate phosphorylation of eNOS on Ser1179. The purpose of this study was to exam-
ine the role of other protein kinases in mediating this Akt-independent phosphorylation of
eNOS.
Age 15-17 weeks 36 weeks >52 weeks
% En-face area 0.5+0.3 n=6 24.1+4.3‡ n=8 46+13.5‡¶ n=6
Sinus plaque (mm sq) 0.31+0.06 n=5 0.65+0.1‡ n=5 1.13+0.14‡¶ n=6
% Plaque Lipid 29.6+7.5 n=6 20.5+4.7‡ n=8 11.1+4.2‡¶ n=6
% Macrophage 14.2+4.5 n=6 10.2+2.7 n=8 5.1+3.1‡¶ n=6
% Collagen 27.7+7.1 n=5 38.4+3.0 n=7 43.4+14‡ n=6
MDA-LDL IgG 0.063+0.024 0.129+0.036‡ 0.064+0.044¶
Cu-oxLDL IgG 0.125+0.036 0.435+0.201 1.049+0.560‡¶
Cu-oxLDL IgM 0.316+0.070 0.560+0.286 1.011+0.356‡
PC IgM 0.419+0.068 0.628+0.276 0.923+0.308‡
IL-4† n=4 0.008+0.004 0.023+0.005 0.062+0.029‡¶
IFN-γ€ n=4 0.015+0.006 0.04+0.014 0.128+0.095‡
IL-10† n=3 0.025+0.018 0.113+0.175 0.247+0.109
